COMMUNIQUÉS West-GlobeNewswire

DiaMedica Therapeutics Announces Results of Annual General and Special Meeting of Shareholders

22/12/2017 - 00:48

MINNEAPOLIS, Dec. 21, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (TSX-V: DMA ) (OTCQB:DMCAF) (the “ Company ”), today announced that at its Annual General and Special Meeting (the “ Meeting ”) of shareholders [...]

La Jolla Pharmaceutical Company Announces FDA Approval of Giapreza™ (angiotensin II)

22/12/2017 - 00:15

Giapreza increases blood pressure in adults with septic or other distributive shock La Jolla to host conference call and webcast at 8:30 a.m. EST on December 22, 2017 SAN DIEGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- La [...]

Forward Pharma Files Final Brief in its Appeal of the U.S. Patent Interference to the Federal Circuit

21/12/2017 - 23:00

COPENHAGEN, Denmark, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (“Forward” or the “Company”) today announced the filing of its reply brief to the U.S. Court of Appeals for the Federal Circuit ( [...]

Akers Biosciences Announces Closing of $6,900,000 Public Offering

21/12/2017 - 22:58

THOROFARE, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or “Akers Bio”), a developer of rapid health information technologies, today announces the closing [...]

Proteostasis Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

21/12/2017 - 22:50

CAMBRIDGE, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (Nasdaq: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]

Humanigen Signs Definitive Agreements to Exchange Loan Obligations for Equity

21/12/2017 - 22:45

Transactions Create Biotechnology Company Focused on Immunotherapy and Oncology Lenzilumab Begins Development for Treating Key Side-Effects Associated with CAR-T BRISBANE, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- [...]

Integra LifeSciences to Present at the 36th Annual J.P. Morgan Healthcare Conference

21/12/2017 - 22:15

PLAINSBORO, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, today announced President and Chief Executive Officer Peter [...]

Ascendis Pharma A/S Announces Participation in 36th Annual J.P. Morgan Healthcare Conference

21/12/2017 - 22:05

COPENHAGEN, Denmark, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare [...]

Fluidigm Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

21/12/2017 - 22:05

SOUTH SAN FRANCISCO, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent [...]

ZIOPHARM to Present at the 36th Annual J.P. Morgan Healthcare Conference

21/12/2017 - 22:05

BOSTON, Dec. 21, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the 36 th Annual J.P. Morgan Healthcare [...]

GenMark Diagnostics to Present at the J.P. Morgan 36th Annual Healthcare Conference

21/12/2017 - 22:03

CARLSBAD, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK ), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief [...]

Altimmune to Participate in the 10th Annual Biotech Showcase in San Francisco, January 8 – 10, 2018

21/12/2017 - 22:01

GAITHERSBURG, Md., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, will provide a [...]

Antares Pharma Provides XYOSTED™ Regulatory Update

21/12/2017 - 22:01

EWING, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced that a written request for a Type A meeting, along with a comprehensive briefing document, have been submitted to the U [...]

ProPhase Labs, Inc. Announces Final Results of Its Tender Offer

21/12/2017 - 22:00

DOYLESTOWN, Pa., Dec. 21, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ) ( www.ProPhaseLabs.com ), a diversified natural health medical science company (“ProPhase”), announced today the final results of [...]

BriaCell Announces Closing of Warrant Incentive Program

21/12/2017 - 20:58

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER U.S. NEWSWIRE SERVICES BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (" BriaCell " or the " Company [...]

Burcon Announces Appointment of David Ju to Its Board of Directors

21/12/2017 - 19:53

VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Corporation”) is pleased to announce the appointment of Mr. David Ju as an [...]

Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum

21/12/2017 - 19:22

SEATTLE, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Arzeda , The Protein Design Company TM , today announced that biotechnology veteran William “Bill” Baum has joined the company’s board of directors. Baum is a highly respected [...]

Yield10 Bioscience Announces Closing of $14.5 Million Public Offering

21/12/2017 - 19:00

WOBURN, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today announced the closing of an underwritten public offering of units for gross proceeds of $14.5 million, which includes the [...]

Sensorion Successfully Closes on a €1.6 Million Euro Placement with Cochlear

21/12/2017 - 18:30

MONTPELLIER, France, Dec. 21, 2017 (GLOBE NEWSWIRE) -- (FR0012596468 — ALSEN) — Sensorion, a biotech specializing in the treatment of inner ear diseases (the "Company"), announces that it has today carried out a capital [...]